Piramal Pharma Ltd Annually Results

Gross Sales

9,151.18

8,171.16

7,081.55

6,559.1

Excise Duty

0

0

0

0

Net Sales

9,151.18

8,171.16

7,081.55

6,559.1

Other Operating Income

0

0

0

0

Other Income

207.74

234.88

279.44

334.83

Total Income

9,358.92

8,406.04

7,360.99

6,893.93

Total Expenditure

7,706.35

7,037.69

6,460.27

5,624.52

PBIDT

1,652.57

1,368.35

900.72

1,269.41

Interest

421.59

448.49

344.18

198.25

PBDT

1,230.98

919.86

556.54

1,071.16

Depreciation

816.34

740.57

676.69

586.18

Minority Interest Before NP

0

0

0

0

Tax

310.12

185.35

110.4

191.13

Deferred Tax

13.39

-23.88

-44.09

-82.11

Reported Profit After Tax

91.13

17.82

-186.46

375.96

Minority Interest After NP

0

0

0

0

Net Profit after Minority Interest

91.13

17.82

-186.46

375.96

Extra-ordinary Items

0

2.12

-0.56

-9.14

Adjusted Profit After Extra-ordinary item

91.13

15.7

-185.9

385.1

EPS (Unit Curr.)

0.69

0.14

-1.57

3.19

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

1.4

1.1

0

5.6

Equity

1,324.35

1,322.95

1,193.32

1,185.91

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

18.05

16.74

12.71

19.35

PBDTM(%)

13.45

11.25

7.85

16.33

PATM(%)

0.99

0.21

-2.63

5.73